Additionally, the levels of the methylation of the TMEFF2 gene were analyzed, and it was found that, regardless of the type of sample, age, race, weight, cancer stage, and tumor differentiation grade, the TMEFF2 exhibited low levels of methylation; however, these levels were higher than those in healthy individuals. This evidence concerns the gene TMEFF2 and neoplasm.